Investor insights
Sectors invested in
Biotechnology4
Health Care3
alcohol abuse2
drug addiction2
alcohol addiction2
Pharmaceutical2
drug abuse2
Molecular Diagnostics1
Molecular Pathology1
Barrett's Esophagus1
Proteomics1
Acid Reflux1
Precision Oncology1
Gastroenterology1
Mass Spectroscopy1
Esophageal Diseases1
Health Diagnostics1
Cancer & Other Disease Detection1
Screening1
Medical1
Funding rounds participated in
$5M sweet spot round size
Most of their 4 investments are in rounds between $2.1M and $5M
Investor type
Family Investment Office
Basic info
Industry
financial services
Date founded
2019
Investments made
A
Adial Pharmaceuticals (NASDAQ: ADIL) raised $5M on July 7, 2021
Investors: Bespoke Growth Partners, Inc. and Keystone Capital Partners LLC
A
Adial Pharmaceuticals (NASDAQ: ADIL) raised $2.1M on March 15, 2021
Investors: Keystone Capital Partners LLC
A
Anpac Bio-Medical Science raised $7M on October 1, 2020
Investors: Keystone Capital Partners LLC
S
Stella Diagnostics raised undisclosed on September 1, 2020
Investors: Keystone Capital Partners LLC